Carl Firth

CEO, ASLAN Pharmaceuticals
  • Founder and Chief Executive Officer of ASLAN Pharmaceuticals
  • Previously Head of Asia Healthcare at Bank of America Merrill Lynch
  • More than 10 years’ experience in commercial and R&D roles at AstraZeneca, including Regional Business Development Director AsiaPac and Director of New Product Development China
  • Holds a PhD from Cambridge University in Molecular Biology (Trinity College), an Executive MBA from London Business School and a degree in Molecular Biology from Cambridge University
  • Independent Director of Singapore’s Exploit Technologies
  • Adjunct Professor at Duke-NUS Medical School